{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T21:59:16Z","timestamp":1717451956096},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T00:00:00Z","timestamp":1488931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.rgmx.2016.12.007","type":"journal-article","created":{"date-parts":[[2017,4,3]],"date-time":"2017-04-03T14:22:13Z","timestamp":1491229333000},"page":"277-286","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recurrencia sintom\u00e1tica relacionada con la enfermedad por reflujo gastroesof\u00e1gico en pacientes que descontin\u00faan los inhibidores de la bomba de protones durante el estudio inal\u00e1mbrico de monitorizaci\u00f3n de pH esof\u00e1gico Bravo \u00ae"],"prefix":"10.1016","volume":"82","author":[{"given":"R.","family":"Schey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.P.","family":"Alla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Midani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.P.","family":"Parkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2016.12.007_bib0095","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2012.08.002","article-title":"Burden of gastrointestinal disease in the United States: 2012 update","volume":"143","author":"Peery","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0100","unstructured":"A Gallup survey on heartburn across America. Princeton, NJ Gallup Organization Inc, March 1988."},{"key":"10.1016\/j.rgmx.2016.12.007_bib0105","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0110","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-140-7-200404060-00011","article-title":"Short-term treatment with proton-pump inhibitors as a test for gastroesophageal reflux disease: A meta-analysis of diagnostic test characteristics","volume":"140","author":"Numans","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0115","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2036.2006.03084.x","article-title":"Discontinuation of proton pump inhibitors in patients on long-term therapy: A double-blind, placebo-controlled trial","volume":"24","author":"Bj\u00f6rnsson","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0120","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/ajg.2011.220","article-title":"Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: Analysis of dexlansoprazole MR clinical trial data","volume":"106","author":"Metz","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000016930","article-title":"Therapeutical trails in treatments of gastroesophageal reflux disease","volume":"18","author":"Fass","year":"2000","journal-title":"Dig Dis"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2036.2004.01868.x","article-title":"Successful oesophageal pH monitoring with a catheter-free system","volume":"19","author":"Ward","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0135","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1572-0241.2003.07398.x","article-title":"Ambulatory esophageal pH monitoring using a wireless system","volume":"98","author":"Pandolfino","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/bmj.e372","article-title":"Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: A prospective cohort study","volume":"344","author":"Khalili","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0145","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/ajg.2010.81","article-title":"Dyspeptic symptoms development after discontinuation of PPI inhibitor: A double-blind placebo-controlled trial","volume":"105","author":"Niklasson","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0150","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/00365521.2012.746395","article-title":"Systematic review: Symptoms of rebound acid hypersecretion following proton pump inhibitor treatment","volume":"48","author":"L\u00f8drup","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.7326\/0003-4819-140-7-200404060-00011","article-title":"Short-term treatment with proton- ump inhibitors as a test for gastroesophageal reflux disease: Ameta-analysis of diagnostic\u00a0test\u00a0characteristics","volume":"140","author":"Neumans","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.11622\/smedj.2014087","article-title":"Inappropriate use of proton pump inhibitors in a local setting","volume":"55","author":"Chia","year":"2014","journal-title":"Singapore Med J"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0165","first-page":"228","article-title":"Magnitude and economic effect of overuseofantisecretory therapy in the ambulatory care setting","volume":"16","author":"Heidelbaugh","year":"2010","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0170","first-page":"105","article-title":"Albumin, length of stay, and proton pump inhibitors: Key factors in Clostridium difficile-associated disease in nursing home patients","volume":"6","author":"Al-Tureihi","year":"2005","journal-title":"J Am Med DirAssoc"},{"key":"10.1016\/j.rgmx.2016.12.007_bib0175","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1001\/jama.294.23.2989","article-title":"Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease","volume":"294","author":"Dial","year":"2005","journal-title":"JAMA"},{"issue":"Suppl. 4","key":"10.1016\/j.rgmx.2016.12.007_bib0180","first-page":"10","article-title":"Clinical and economic consequences of dyspepsia in the community","volume":"50","author":"Moayyedi","year":"2002","journal-title":"Gut"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037509061730040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037509061730040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T01:30:40Z","timestamp":1535938240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037509061730040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S037509061730040X"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2016.12.007","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrencia sintom\u00e1tica relacionada con la enfermedad por reflujo gastroesof\u00e1gico en pacientes que descontin\u00faan los inhibidores de la bomba de protones durante el estudio inal\u00e1mbrico de monitorizaci\u00f3n de pH esof\u00e1gico Bravo\u00ae","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}